Skip to Content
Merck
  • Pore networks and polymer rearrangement on a drug-eluting stent as revealed by correlated confocal Raman and atomic force microscopy.

Pore networks and polymer rearrangement on a drug-eluting stent as revealed by correlated confocal Raman and atomic force microscopy.

Langmuir : the ACS journal of surfaces and colloids (2012-04-27)
Kevin B Biggs, Karin M Balss, Cynthia A Maryanoff
ABSTRACT

Drug release from and coating morphology on a CYPHER sirolimus-eluting coronary stent (SES) during in vitro elution were studied by correlated confocal Raman and atomic force microscopy (CRM and AFM, respectively). Chemical surface and subsurface maps of the SES were generated in the same region of interest by CRM and were correlated with surface topography measured by AFM at different elution times. For the first time, a direct correlation between drug-rich regions and the coating morphology was made on a drug-eluting medical device, linking drug release with pore formation, pore throats, and pore networks. Drug release was studied on a drug-eluting stent (DES) system with a multicomponent carrier matrix (poly(n-butyl methacrylate) [PBMA] and poly(ethylene-co-vinyl acetate) [PEVA]). The polymer was found to rearrange postelution because confluence of the carrier polymer matrix reconstituted the voids created by drug release.

MATERIALS
Product Number
Brand
Product Description

Sigma-Aldrich
Poly(ethylene-co-vinyl acetate), vinyl acetate 18 wt. %, melt index 8 g/10 min (190°C/2.16kg), contains 200-900 ppm BHT as inhibitor
Sigma-Aldrich
Poly(ethylene-co-vinyl acetate), vinyl acetate 12 wt. %, melt index 8 g/10 min (190°C/2.16kg)
Sigma-Aldrich
Poly(ethylene-co-vinyl acetate), vinyl acetate 40 wt. %, melt index (41-63 dg/min (190°C/2.16kg)), contains 190-910 ppm inhibitor